{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:27:33Z","timestamp":1760189253037},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,2,3]],"date-time":"2012-02-03T00:00:00Z","timestamp":1328227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1007\/s11926-012-0237-7","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T13:29:51Z","timestamp":1328621391000},"page":"116-120","source":"Crossref","is-referenced-by-count":6,"title":["The Clinical Spectrum of Juvenile Idiopathic Arthritis in a Large Urban Population"],"prefix":"10.1007","volume":"14","author":[{"given":"Melissa S.","family":"Tesher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen B.","family":"Onel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,3]]},"reference":[{"key":"237_CR1","doi-asserted-by":"crossref","unstructured":"Petty RE, Cassidy JT. Chronic arthritis in childhood. In: Cassidy, Petty, Laxer, Lindsley, editors. Textbook of pediatric rheumatology, 6th edn. Philadelphia. 2011.","DOI":"10.1016\/B978-1-4160-6581-4.10002-0"},{"key":"237_CR2","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1176\/ajp.137.5.535","volume":"137","author":"GL Engel","year":"1980","unstructured":"Engel GL. The clinical application of the biopsychosocial model. Am J Psychiatry. 1980;137:535\u201344.","journal-title":"Am J Psychiatry"},{"key":"237_CR3","unstructured":"Humes KR, Jones NA, Ramirez RR. Overview of race and Hispanic origin: 2010. Issued March 2011 by the United States Census Bureau and available at https:\/\/www.census.gov\/prod\/cen2010\/briefs\/c2010br-02.pdf ; p.4."},{"key":"237_CR4","unstructured":"Hobbs F, Stoops N. Demographic trends in the 20th century: Census 2000 special reports. Issued November 2002 by the United States Census Bureau and available at http:\/\/www.census.gov\/prod\/2002pubs\/censr-4.pdf ; p. 101."},{"key":"237_CR5","unstructured":"Frey WH. State of America: Race and Ethnicity. Available at http:\/\/www.brookings.edu\/\u223c\/media\/Files\/Programs\/Metro\/state_of_metro_america\/metro_america_chapters\/metro_america_race.pdf ."},{"key":"237_CR6","unstructured":"DeNavas Walt C, Proctor B, Smith J. Income, poverty and health insurance coverage in the United States. 2010. pp 24\u201328. Issued by the United States Census Bureau and available at: http:\/\/www.census.gov\/prod\/2011pubs\/p60-239.pdf ."},{"key":"237_CR7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","volume":"372","author":"P Emery","year":"2008","unstructured":"Emery P, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in early, moderate to severe rheumatoid arthritis (COMET): a randomized, double-blind, parallel treatment trial. Lancet. 2008;372:375\u201382.","journal-title":"Lancet"},{"key":"237_CR8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.21519","volume":"54","author":"C Breedveld","year":"2006","unstructured":"Breedveld C, et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum. 2006;54:26\u201337.","journal-title":"Arthritis Rheum"},{"key":"237_CR9","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1136\/ard.2010.143347","volume":"70","author":"P Tynjala","year":"2011","unstructured":"Tynjala P, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomized open-label clinical trial. Ann Rheum Dis. 2011;70:1605\u201312.","journal-title":"Ann Rheum Dis"},{"key":"237_CR10","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3899\/jrheum.080560","volume":"36","author":"A Magnani","year":"2009","unstructured":"Magnani A, et al. Achievement of a state of inactive disease at least once in the first 5 years predicts better outcome of patients with polyarticular juvenile idiopathic arthritis. J Rheumatol. 2009;36:628\u201334.","journal-title":"J Rheumatol"},{"key":"237_CR11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/art.24671","volume":"61","author":"N Tzabarichev","year":"2009","unstructured":"Tzabarichev N, et al. Predictors of delayed referral to a pediatric rheumatology center. Arthritis Care Res. 2009;61:1367\u201372.","journal-title":"Arthritis Care Res"},{"key":"237_CR12","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/art.22882","volume":"57","author":"HE Foster","year":"2007","unstructured":"Foster HE, et al. Delay in access to appropriate care for children presenting with musculoskeletal symptoms and ultimately diagnosed with juvenile idiopathic arthritis. Arthritis Care Res. 2007;57:921\u20137.","journal-title":"Arthritis Care Res"},{"key":"237_CR13","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3899\/jrheum.100083","volume":"37","author":"NJ Shiff","year":"2010","unstructured":"Shiff NJ, et al. Factors associated with a longer time to access pediatric rheumatologists in Canadian children with juvenile idiopathic arthritis. J Rheumatol. 2010;37:2415\u201321.","journal-title":"J Rheumatol"},{"key":"237_CR14","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMsa1013285","volume":"364","author":"J Bisgaier","year":"2011","unstructured":"\u2022 Bisgaier J, Rhodes K. Auditing access to specialty care for children with public insurance. N Engl J Med. 2011;364:2324\u201333. Children with public insurance have starkly reduced access to pediatric subspecialty care. Many offices will not schedule a publicly insured child at all. Even in offices that accept public insurance, publicly insured patients must wait longer to be evaluated.","journal-title":"N Engl J Med"},{"key":"237_CR15","first-page":"1475","volume":"34","author":"B Bruce","year":"2007","unstructured":"Bruce B, Fries JF, Murtagh KN. Health status disparities in ethnic minority patients with rheumatoid arthritis: a cross-sectional study. J Rheumatol. 2007;34:1475\u20139.","journal-title":"J Rheumatol"},{"key":"237_CR16","first-page":"870","volume":"33","author":"D Ang","year":"2006","unstructured":"Ang D, et al. Patient\u2019s ethnicity does not influence utilization of effective therapies in rheumatoid arthritis. J Rheumatol. 2006;33:870\u20138.","journal-title":"J Rheumatol"},{"key":"237_CR17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/art.21991","volume":"55","author":"HI Brunner","year":"2006","unstructured":"Brunner HI, et al. Differences in disease outcomes between Medicaid and privately insured children: possible health disparities in juvenile rheumatoid arthritis. Arthritis Rheum. 2006;55:378\u201384.","journal-title":"Arthritis Rheum"},{"key":"237_CR18","first-page":"716","volume":"60 Suppl 10","author":"E Levey","year":"2009","unstructured":"Levey E, et al. Health literacy in childhood arthritis (abstract). Arthritis Rheum. 2009;60 Suppl 10:716.","journal-title":"Arthritis Rheum"},{"key":"237_CR19","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/art.20536","volume":"51","author":"DE Feldman","year":"2004","unstructured":"Feldman DE, et al. Factors associated with the use of complementary and alternative medicine in juvenile idiopathic arthritis. Arthritis Rheum (Arthritis Care Res). 2004;51:527\u201332.","journal-title":"Arthritis Rheum (Arthritis Care Res)"},{"key":"237_CR20","first-page":"236","volume":"20","author":"T Zaman","year":"2007","unstructured":"Zaman T, Agarwal S, Handa R. Complementary and alternative medicine use in rheumatoid arthritis: an audit of patients visiting a tertiary care center. Natl Med J India. 2007;20:236\u20139.","journal-title":"Natl Med J India"},{"key":"237_CR21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10067-007-0646-6","volume":"27","author":"MS Lee","year":"2008","unstructured":"Lee MS, et al. Use of complementary and alternative medicine by rheumatoid arthritis patients in Korea. Clin Rheumatol. 2008;27:29\u201333.","journal-title":"Clin Rheumatol"},{"key":"237_CR22","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/jpepsy\/jsm033","volume":"32","author":"K Zebracki","year":"2007","unstructured":"Zebracki K, et al. Brief report: use of complementary and alternative medicine and psychological functioning in Latino children with juvenile idiopathic arthritis or arthralgias. J Pediatr Psychol. 2007;32:1006\u201310.","journal-title":"J Pediatr Psychol"},{"key":"237_CR23","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10067-007-0816-6","volume":"27","author":"A Garcia-Gonzalez","year":"2008","unstructured":"Garcia-Gonzalez A, et al. Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol. 2008;27:883\u20139.","journal-title":"Clin Rheumatol"},{"key":"237_CR24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/art.21988","volume":"55","author":"Berrios-Rivera","year":"2006","unstructured":"Berrios-Rivera, et al. Trust in physicians and elements of the medical interaction in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. 2006;55:385\u201393.","journal-title":"Arthritis Care Res"},{"key":"237_CR25","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/MLR.0b013e31818af829","volume":"47","author":"F Constantinescu","year":"2009","unstructured":"\u2022 Constantinescu F, et al. Racial disparities in treatment preferences for rheumatoid arthritis. Medical Care. 2009;47:350\u20135. Medical decision making is notably different in African Americans compared with Caucasians. African Americans are far more risk averse and are particularly affected by increased risks of cancer due to treatments.","journal-title":"Med Care"},{"key":"237_CR26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/art.24338","volume":"61","author":"F Constantinescu","year":"2009","unstructured":"Constantinescu F, et al. Understanding why rheumatoid arthritis patient treatment preferences differ by race. Arthritis Care Res. 2009;61:413\u20138.","journal-title":"Arthritis Care Res"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-012-0237-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-012-0237-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-012-0237-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T05:13:57Z","timestamp":1561266837000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-012-0237-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["237"],"URL":"https:\/\/doi.org\/10.1007\/s11926-012-0237-7","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,3]]}}}